Back to Search
MURALI CHINTAGUMPALA, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1386724714Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
J1635(TX)
Research & Publications (20)
A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.
PMID 18796696·Neuro Oncol·2009
4-observational
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.
PMID 16314955·J Neurooncol·2006
3-trial
Phase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer.
PMID 15514381·J Clin Oncol·2004
3-trial
Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
PMID 18501529·Int J Radiat Oncol Biol Phys·2009
3-trial
Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma.
PMID 19653709·Arch Pathol Lab Med·2009
8-other
Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma.
PMID 18485616·Int J Radiat Oncol Biol Phys·2009
3-trial
Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma.
PMID 18952980·Neuro Oncol·2009
8-other
Acquired von Willebrand syndrome and Wilms tumor: not always benign.
PMID 19006222·Pediatr Blood Cancer·2009
5-case
Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
PMID 19119907·J Neurosurg Pediatr·2009
8-other
Cellular mesoblastic nephroma (infantile renal fibrosarcoma): institutional review of the clinical, diagnostic imaging, and pathologic features of a distinctive neoplasm of infancy.
PMID 19629465·Pediatr Radiol·2009
5-case
Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy.
PMID 19340853·Pediatr Blood Cancer·2009
5-case
Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma.
PMID 18567798·Mol Cancer Res·2008
7-preclinical
Intensity-modulated radiation therapy in childhood ependymoma.
PMID 18258381·Int J Radiat Oncol Biol Phys·2008
8-other
Radiation-induced malignant gliomas: is there a role for reirradiation?
PMID 18262733·Int J Radiat Oncol Biol Phys·2008
6-review
Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma.
PMID 18403755·Stem Cells·2008
7-preclinical
Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma.
PMID 18421716·Pediatr Blood Cancer·2008
8-other
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.
PMID 18669462·J Clin Oncol·2008
2-rct
Results of treatment of patients with superficial facial rhabdomyosarcomas on protocols of the Intergroup Rhabdomyosarcoma Study Group (IRSG), 1984-1997.
PMID 18240175·Pediatr Blood Cancer·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6701 FANNIN ST
HOUSTON, TX 77030 - Phone
- (832) 822-4240
Quick Facts
- NPI
- 1386724714
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile